- Home
- MDGL
as 06-18-2025 11:38am EST
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | WEST CONSHOHOCKEN |
| Market Cap: | 6.1B | IPO Year: | N/A |
| Target Price: | $420.63 | AVG Volume (30 days): | 306.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -17.97 | EPS Growth: | N/A |
| 52 Week Low/High: | $200.63 - $377.46 | Next Earning Date: | 08-06-2025 |
| Revenue: | $317,383,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | 286.17% | Revenue Growth (next year): | 64.17% |
Latest Madrigal Pharmaceuticals Inc. News
MDGL Breaking Stock News: Dive into MDGL Ticker-Specific Updates for Smart Investing
GlobeNewswire
20 hours ago
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Simply Wall St.
6 days ago
Exploring High Growth Tech Stocks In The US Market
GlobeNewswire
16 days ago
Madrigal Pharmaceuticals to Participate in the 46th Annual Global Goldman Sachs Health Care Conference
Yahoo Finance
18 days ago
This week in Trumponomics: Too bad TACO isn’t true
The Guardian
18 days ago
Starmer says Farage would spook the City and give us Truss 2 – he could be right
Yahoo Finance Video
18 days ago
AI ecosystem isn't just Nvidia: Unlock it further with this ETF
Reuters
18 days ago
Ford recalls more than 29,000 vehicles in the US, NHTSA says
USA TODAY
18 days ago
Smoke from Canadian wildfires worsens air quality in Dakotas, Midwestern states
Compare MDGL vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MDGL Madrigal Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.